NEW YORK (AP) — NEW YORK (AP) — Neurogene Inc. (NGNE) on Friday reported a loss of $18.5 million in its second quarter.
The New York-based company said it had a loss of $1.09 per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.02 per share.
The drugmaker posted revenue of $925,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NGNE at https://www.zacks.com/ap/NGNE
